60 related articles for article (PubMed ID: 7433273)
21. Prognostic factors determining survival in differentiated thyroid cancer.
Gulcelik MA; Gulcelik NE; Kuru B; Camlibel M; Alagol H
J Surg Oncol; 2007 Dec; 96(7):598-604. PubMed ID: 17708543
[TBL] [Abstract][Full Text] [Related]
22. External beam radiotherapy for differentiated thyroid cancer.
Meadows KM; Amdur RJ; Morris CG; Villaret DB; Mazzaferri EL; Mendenhall WM
Am J Otolaryngol; 2006; 27(1):24-8. PubMed ID: 16360819
[TBL] [Abstract][Full Text] [Related]
23. Review of distribution of nodal disease in differentiated thyroid cancers in an oncosurgical center in Sri Lanka.
Amarasinghe IY; Perera NM; Bahinathan N; Marzook HH; Peiris AK
Ann Surg Oncol; 2007 May; 14(5):1560-4. PubMed ID: 17318279
[TBL] [Abstract][Full Text] [Related]
24. Poorly differentiated thyroid carcinomas defined on the basis of mitosis and necrosis: a clinicopathologic study of 58 patients.
Hiltzik D; Carlson DL; Tuttle RM; Chuai S; Ishill N; Shaha A; Shah JP; Singh B; Ghossein RA
Cancer; 2006 Mar; 106(6):1286-95. PubMed ID: 16470605
[TBL] [Abstract][Full Text] [Related]
25. Familial non-medullary thyroid cancer: a matched-case control study.
Maxwell EL; Hall FT; Freeman JL
Laryngoscope; 2004 Dec; 114(12):2182-6. PubMed ID: 15564841
[TBL] [Abstract][Full Text] [Related]
26. Clinicopathologic evaluation of immunohistochemical CD147 and MMP-2 expression in differentiated thyroid carcinoma.
Tan H; Ye K; Wang Z; Tang H
Jpn J Clin Oncol; 2008 Aug; 38(8):528-33. PubMed ID: 18664479
[TBL] [Abstract][Full Text] [Related]
27. Re: Extent of surgery affects papillary thyroid cancer.
Shah JP
Ann Surg; 2008 Jun; 247(6):1082-3; author reply 1083-4. PubMed ID: 18520248
[No Abstract] [Full Text] [Related]
28. Microsatellite instability in thyroid cancer: hot spots, clinicopathological implications, and prognostic significance.
Onda M; Nakamura I; Suzuki S; Takenoshita S; Brogren CH; Stampanoni S; Li D; Rampino N
Clin Cancer Res; 2001 Nov; 7(11):3444-9. PubMed ID: 11705861
[TBL] [Abstract][Full Text] [Related]
29. [Limited radical approach in differentiated thyroid gland cancers. A prospective study of 107 patients].
Engel U; Kucharski A; Zornig C
Chirurg; 1994 Dec; 65(12):1095-8; discussion 1098-9. PubMed ID: 7851141
[TBL] [Abstract][Full Text] [Related]
30. [Radioiodine therapy and radioiodine after-care in differentiated thyroid gland carcinomas].
Börner AR; Müller-Gärtner HW
Zentralbl Chir; 1997; 122(4):274-85. PubMed ID: 9221638
[TBL] [Abstract][Full Text] [Related]
31. OCT4 expression on a case of poorly differentiated (insular) carcinoma of the thyroid gland and minireview.
Ruangpratheep C; Lohachittranond C; Poonpracha T; Punyarit P
J Med Assoc Thai; 2005 Nov; 88 Suppl 3():S281-9. PubMed ID: 16858970
[TBL] [Abstract][Full Text] [Related]
32. HLA class II expression in well differentiated thyroid carcinoma: correlation with clinicopathological features.
Knoll MR; Schwab M; Oestreich K; Rumstadt B; Hagmüller E
J Exp Clin Cancer Res; 1997 Jun; 16(2):177-82. PubMed ID: 9261744
[TBL] [Abstract][Full Text] [Related]
33. Need for a revised staging consensus in medullary thyroid carcinoma.
Boostrom SY; Grant CS; Thompson GB; Farley DR; Richards ML; Hoskin TL; Hay ID
Arch Surg; 2009 Jul; 144(7):663-9. PubMed ID: 19620547
[TBL] [Abstract][Full Text] [Related]
34. Operative strategy for follicular thyroid cancer in risk groups stratified by pTNM staging.
Lin JD; Chao TC; Chen ST; Huang YY; Liou MJ; Hsueh C
Surg Oncol; 2007 Aug; 16(2):107-13. PubMed ID: 17600699
[TBL] [Abstract][Full Text] [Related]
35. Prognostic factors in well-differentiated thyroid carcinoma in patients treated and followed in the same institution.
Cappelli C; Pirola I; Braga M; De Martino E; Morassi ML; Gandossi E; Mattanza C; Balzano R; Castellano M; Rosei EA
Ann Ital Chir; 2006; 77(2):107-13. PubMed ID: 17147082
[TBL] [Abstract][Full Text] [Related]
36. Prognostic factors in patients with differentiated thyroid carcinoma.
Steinmüller T; Klupp J; Rayes N; Ulrich F; Jonas S; Gräf KJ; Neuhaus P
Eur J Surg; 2000 Jan; 166(1):29-33. PubMed ID: 10688213
[TBL] [Abstract][Full Text] [Related]
37. Papillary thyroid cancer: high inter-(simple sequence repeat) genomic instability in a typically indolent cancer.
Wiseman SM; Loree TR; Rigual NR; Hicks WL; Winston JS; Swede H; Bartos JD; Anderson GR; Stoler DL
Head Neck; 2003 Oct; 25(10):825-32. PubMed ID: 12966506
[TBL] [Abstract][Full Text] [Related]
38. [Changes of the phosphorus uptake of thyroid neoplasms under the influence of exogenous triiodothyronine].
Gozariu I; Cristoloveanu E; Holan T; Derevenco V; Szasz A
Stud Cercet Endocrinol; 1967; 18(6):505-10. PubMed ID: 6082527
[No Abstract] [Full Text] [Related]
39. [Morphological and histochemical criteria of malignancy of thyroid epitheliomas].
Laumonier R; Laquerrière R; Nassif N
Rev Lyon Med; 1965 Jun; 14(11):501-16. PubMed ID: 5841138
[No Abstract] [Full Text] [Related]
40. [Various parameters of cellular mass metabolism in highly differentiated thyroid cancer].
Sznapka Z
Pol Przegl Chir; 1980 Aug; 52(8):665-8. PubMed ID: 7433273
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
